Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases

Details for Australian Patent Application No. 2002301907 (hide)

Owner Beth Israel Deaconess Medical Center Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.

Inventors Fischer, Gunter; Cantley, Lewis C; Yaffee, Michael; Lu, Kun Ping

Agent Pizzeys

Pub. Number AU-B-2002301907

Parent 27032

Filing date 8 November 2002

Wipo publication date 13 March 2003

Acceptance publication date 4 January 2007

International Classifications

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 1/00 (2006.01) General processes for the preparation of peptides

C07K 1/04 (2006.01) General processes for the preparation of peptides

Event Publications

28 November 2002 Complete Application Filed

13 March 2003 Application Open to Public Inspection

  Published as AU-B-2002301907

4 January 2007 Application Accepted

  Published as AU-B-2002301907

9 August 2007 Standard Patent Sealed

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002301908-Self-propelled, intraluminal device with working channel and method of use

2002301906-Sporting footwear